VR Foundation

25 Followers

52 SlideShares 25 Followers

52 SlideShares 25 Followers

Firmly committed to curing vitiligo pigment disorder, the VR Foundation is a non-profit organization funding and fast-tracking medical research globally. Our mission is to develop effective treatments for millions of people around the world who suffer from vitiligo. VR Foundation operates as a disease-specific non-profit organization, with a small internal staff managing academic research, clinical and outreach programs. VR Foundation has assembled a strong team of leading research scientists, doctors, pharma and technology development professionals, and provided them with an infrastructure enabling the team to identify, understand and validate promising solutions quickly.

vitiligo melanoma dermatology pigmentary disorders vrf epidemiology cure melanocytes antioxidants melanocyte cloud computing bio it foundation news sodium korobko research progression immunomodulator yan vr treatment oxodihydroacridinylacetate valle igor drug stop 2013 rare diseases samples biobank vitiligo research review cure. vrf cover combination therapy nyam light therapy halonaevus prevention depigmentation vitiligo. melanocytes sun exposure hormons melasma therapy pigmentation lichen acrofacial puva incontinentia pigmenti permanent psoriasis skin lesions hepato splenic pruritus erythema naevi anti-tnf grafting surgery gst genetic pigmentation disorders case cryotherapy photoprotection lesions myths skin melanocite pigmentary biotechnology virus витилиго white spots emmy genetics

Präsentationen
Dokumente
Infografiken

Aktuellste Beliebteste SlideShares

Vitiligo research foundation-achievements,_present,_future_trends_2017

Vor 6 Jahren • 38 Aufrufe

Vitiligo conference in vietnam 2017

Vor 6 Jahren • 27 Aufrufe

состояние проблемы витилиго в республике казахстан

Vor 9 Jahren • 412 Aufrufe

Sodium Oxodihydroacridinylacetate for effective vitiligo treatment. May 24, 2013

Vor 10 Jahren • 434 Aufrufe

Vitiligo biobank presentation dec 2012 yv ik

Vor 11 Jahren • 182 Aufrufe

Vrf presentation december 2012

Vor 11 Jahren • 215 Aufrufe

Roundtable on vitiligo_v2-1_ ceo

Vor 11 Jahren • 159 Aufrufe

Vrf master class_in_China_speaker_information_简介

Vor 11 Jahren • 347 Aufrufe

Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy of Dermatology, Prof. Torello Lotti March 13, 2012

Vor 12 Jahren • 2185 Aufrufe

Home, targeted (non-laser) phototherapy for early vitiligo .Dr Viktoria Eleftheriadou MD

Vor 12 Jahren • 392 Aufrufe

Halonaevus vitiligo mc Dr Elke Janig Austria

Vor 12 Jahren • 377 Aufrufe

Phisical treatments in Vitiligo - Prof. Lotti Torello, MD

Vor 12 Jahren • 383 Aufrufe

Melanoma epidemiology, etiopathogenesis and prevention - Professor Torello Lotti, MD - University G.Marconi, Rome, Italy - and Linda Tognetti, MD - Department of Dermatologic Sciences University of Florence, Italy

Vor 12 Jahren • 953 Aufrufe

Melasma – epidemiology, classification - Prof. Torello Lotti, MD

Vor 12 Jahren • 1070 Aufrufe

Vitiligo: epidemiology and pathophysiology - Prof.Torello Lotti, MD

Vor 12 Jahren • 688 Aufrufe

Controversies in melanoma -Professor Torello Lotti, MD - University G.Marconi, Rome, Italy - and Linda Tognetti, MD - Department of Dermatologic Sciences University of Florence, Italy

Vor 12 Jahren • 1031 Aufrufe

Combination therapy - Prof.TorelloLotti , MD

Vor 12 Jahren • 559 Aufrufe

Biology of melanocyte - Professor Torello Lotti, MD - University G.Marconi, Rome, Italy - and Linda Tognetti, MD - Department of Dermatologic Sciences University of Florence, Italy

Vor 12 Jahren • 1083 Aufrufe

DLQI SCORE IN VITILIGO PATIENTS IN RE-MEDIKA HOSPITAL Cross-sectional study - Dr.Teovska

Vor 12 Jahren • 223 Aufrufe

ACROFACIAL VITILIGO

Vor 12 Jahren • 343 Aufrufe